ema prac tirzepatide naion review 2025 #Mounjaro & eyesight…. reality. The “blindness” stories are mostly about (an eye-stroke). A large study found a very small increase (0.04% vs 0.02%) in people on #semaglutide / #tirzepatide Semaglutide-associated risk of nonarteritic anterior

Future of Semaglutide Treatments Current studies on semaglutide suggest it may help with more than diabetes and weight loss

Well see what happens

Mounjaro may have a coverage pathway for Apple Health members with a documented type 2 diabetes diagnosis, but Zepbound and compounded tirzepatide are generally excluded

Additionally, regular blood sugar monitoring and management are critical to help minimize the risk of serious eye problems that may be associated with the drug

Several physiological and clinical factors can influence tirzepatide pharmacokinetics, potentially affecting drug levels and therapeutic response

19 This discrepancy highlights the gap between efficacy observed in controlled trial settings and effectiveness in routine clinical practice